Skip to main content

Exploring the Evolving Field of Chronic Graft-Versus-Host Disease: Management Strategies

Course Experts: Melinda Cook, PharmD and Eno Inyang, PharmD, BCPS, BCOP

Course Description: This course examines chronic GVHD pathophysiology, novel treatment options, evaluates prophylactic therapies for prevention, and analyzes treatments for both steroid-naïve and steroid-refractory cases.

Credits: CEUs will be granted for pharmacists in disease state management/drug therapy.

Chronic Graft-Versus-Host Disease (GVHD), Prophylactic Therapies, Steroid-Naive, Steroid Refractory, Hematopoietic Stem Cell Transplant, Autologous Transplant, Allogeneic Transplant, Acute GVHD, Chronic GVHD, Immunosuppression, Thrombocytopenia, Cytokines, Endothelial Damage, Fibrosis, Tacrolimus, Methotrexate, Cyclophosphamide, Mycophenolate, Ibrutinib, Ruxolitinib